Fortress Biotech Inc [FBIO] stock is trading at $1.43, down -1.04%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FBIO shares have gain 2.88% over the last week, with a monthly amount drifted -29.56%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Ladenburg Thalmann started tracking the stock with Buy rating on August 04, 2022, and set its price target to $6. On October 02, 2020, The Benchmark Company initiated with a Buy rating and assigned a price target of $9 on the stock. B. Riley FBR started tracking the stock assigning a Buy rating and suggested a price target of $9 on December 18, 2019. B. Riley FBR Inc. initiated its recommendation with a Buy and recommended $10 as its price target on February 28, 2018. Rodman & Renshaw started tracking with a Buy rating for this stock on July 11, 2017, and assigned it a price target of $11. In a note dated March 22, 2017, JMP Securities initiated an Mkt Outperform rating.
Fortress Biotech Inc [FBIO] stock has fluctuated between $1.24 and $5.25 over the past year. Fortress Biotech Inc [NASDAQ: FBIO] shares were valued at $1.43 at the most recent close of the market.
Analyzing the FBIO fundamentals
Fortress Biotech Inc [NASDAQ:FBIO] reported sales of 82.62M for the trailing twelve months, which represents a drop of -14.32%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -1.18%, Pretax Profit Margin comes in at -0.85%, and Net Profit Margin reading is -0.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -2.27 and Total Capital is -1.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 4.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3900 points at the first support level, and at 1.3500 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4850, and for the 2nd resistance point, it is at 1.5400.
Ratios To Look Out For
For context, Fortress Biotech Inc’s Current Ratio is 1.37. In addition, the Quick Ratio stands at 1.24 and the Cash Ratio stands at 1.01. Considering the valuation of this stock, the price to sales ratio is 0.48, the price to book ratio is 1.81.
Transactions by insiders
Recent insider trading involved ROSENWALD LINDSAY A MD, PRESIDENT, CEO & CHAIRMAN, that happened on Sep 23 ’24 when 0.76 million shares were purchased. President, CEO & Chairman, ROSENWALD LINDSAY A MD completed a deal on Jul 11 ’24 to buy 5000.0 shares. Meanwhile, Chief Financial Officer Jin David bought 500.0 shares on Jul 10 ’24.
